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Abstract. Carbon tetrachloride is an organic solvent known for its hepatotoxicity. Its effects 
are due to CCl3· radical production. Chitosan is a natural antioxidant obtained from the exoskeleton of 
the crustaceous; it protects the liver against the oxidative stress. We used 40 female Wistar rats 
(weight 230±25 gr.) divided into 4 equal groups. Group I was the control one; Group II received a 
unique dose of 3 ml/kg CCl4 by gavage; Group III received daily 5 mg/kg vitamin E i.m. for a week 
before the CCl4 administration. Group IV received daily 3 mg/kg chitosan i.p. for a week before the 
CCl4 administration. 24 hours after the CCl4 have been given, blood and liver tissue samples were 
taken. We assessed the oxidative stress markers (malondialdehyde) and antioxidant defence markers 
(hydrogen donors’ capacity and reduced glutathione) both from serum and liver tissue. CCl4 acute 
administration induced oxidative stress especially in the liver tissue (malondialdehyde level increases, 
while glutathione level decreased). However, for the animals that have been protected with chitosan, 
the oxidative stress markers had almost similar values to those of the control group. The 
histopathological findings confirm the results. Therefore, chitosan has a protective effect against liver 
injuries induced by acute exposure to CCl4. 
 




The Reactive Oxygen Species (ROS) play an important role in the pathogenesis of the 
toxic hepatitis. In the liver tissue there are multiple ROS sources: the phagocyte membrane 
NADPH-oxidase; the xantin-oxidase system during the hepatic ischemia-reperfusion process 
and the microsomal enzymes (Mureşan, 1997). 
Among the toxic substances metabolized by the liver are some organic solvents, the 
most import of them being carbon tetrachloride (CCl4), quite frequently used in the industry 
and formerly used as an anaesthetic (Avram, 1994; NeniŃescu, 1980).  
Carbon tetrachloride – a lipid soluble substance – can pass through membrane of the 
hepatocytes. It is metabolized at the microsomal level where are specific p450 cytochroms. 
There the CCl4 is transformed into CCl3·, which attacks especially the lipids of the 
membranes (Chen et al., 2000; Sun et al., 2001; Croquet et al., 2003; Ichi et al., 2009). 
Antioxidants’ supplementation generally has a positive effect on the 
oxidants/antioxidants equilibrium. Among the classic antioxidant substances, vitamin E is a 
free-radicals scavenger and neutralise the CCl3· radicals, reducing thus the oxidative stress in 
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the hepatocytes (Farrell, 1994). Chitosan is a natural product obtained by the deacetylation of 
the chitin, which forms the exoskeleton the crustaceous. Its effect depends on the molecular 
weight (Suzuki et al., 1999; Tomida et al., 2009). 
The aim of the present study was to asses the effect of the chitosan (a natural 
antioxidant substance) supplementation in comparison with that of the vitamin E (a classic 
antioxidant) on the oxidant/antioxidant equilibrium in the acute hepatitis induced by CCl4 
administration. 
MATERIALS AND METHODS 
 
We used 40 female Wistar rats (Rattus Norvegicus, strain Wistar), weight 230±20 gr., 
divided into four equal groups. They were kept room temperature (23±2oC), with 12 hours 
light-dark cycle, food and water ad libitum. They were allowed to acclimate for 1 week prior 
to experimental procedures.  
Group I (n=10) was the control group; blood was obtained from the retroorbitar sinus 
and then liver tissue samples have been taken. The rats in group II (n=10) received a unique 
dose of 3 ml/kg of CCl4 through gavage. The animals from group III (n=10) received i.m. 
daily, for a week, 5 mg/kg vitamin E; in the seventh day they received a unique dose of 3 
ml/kg of CCl4 through gavage. The animals from group IV (n=10) received i.p. daily, for a 
week, 3 mg/kg chitosan (Sigma-Aldrich®, medium molecular weight 190-310 kDa, 
acetylation degree 75-85%; the original solution contained 1 gr. chitosan/1000 ml acetic acid 
0.1% brought, before use, to a neutral pH); in the seventh day they received a unique dose of 
3 ml/kg of CCl4 through gavage; 24 hours after the CCl4 have been given, blood and liver 
tissues samples were taken. 
We assessed from the blood serum and from the liver tissue markers of the oxidative 
stress, malondialdehyde (MDA) using the fluorimetric method (Conti et. al., 1991) and the 
markers of the antioxidant defence: hydrogen donors’ capacity (HDC), using Janaszewska 
method (2002) and reduced glutathione (GSH), using the fluorimetric method (Hu, 1994).  
Also, we explored the histological changes using a Masson’s trichrome stain. The 
obtained data have been statistically analysed using SPSS 13.0.  
 
RESULTS AND DISCUSSIONS 
 
We assessed the descriptive statistics (mean, standard deviation, median, skewness 
and kurtosis). The mean values of the four experimental groups are presented in Tab. I and II. 
Since the distribution of the data was non-Gaussian, we compared the groups using non-
parametric tests (Mann-Whitney). We considered significant differences at p<0.05.  
 
 Tab. 1 








I 1.25±0.30 34.43±4.17 5.61±0.64 
II 1.85±0.34 34.44±6.18 27.92±14.48 
III 1.74±0.26 33.97±4.08 14.82±3.04 















I 0.07±0.01 24.44±3.13 2.07±1.63 
II 0.11±0.07 31.58±8.18 1.31±0.59 
III 0.10±0.03 23.31±5.69 0.68±0.37 
IV 0.09±0.02 25.34±3.19 0.94±0.74 
 
The Mann-Whitney test demonstrated statistically significant differences between the 
malondialdehyde level of the four groups both in blood serum and in liver tissue. These 
results are illustrated in figures 1 and 2.  
 
  
Fig. 1. The differences between total malondialdehyde 
serum levels 
Fig. 4. The differences between liver tissue 
malondialdehyde levels 
 
Acute carbon tetrachloride administration stimulates lipid peroxidation and increases 
total MDA level both in the serum and in the liver tissue. Both vitamin E and chitosan 
supplementation reduce only blood MDA levels, as compared with the CCl4 group, but this 
effect is statistical significant only for the chitosan, which decrease the MDA to a level 
similar with that of the control group. Our results are consistent with those found in the 
literature. Yu et al. (2007) demonstrated that CCl4 administration increases the ROS levels, 
leads to lipid peroxidation and to high MDA levels. Similar results have been found by Login 
et al. (2006) after chronic CCl4 administration. Also, MacDonald-Wicks and Garg (2003) 
showed that vitamin E administration reduces the lipid peroxidation. 
The differences between hydrogen donors’ capacity levels are show in figures 3 and 4, 
while those between the reduced glutathione levels can be observed in figures 5 and 6. Carbon 
tetrachloride increases the hydrogen donors’ capacity in the liver tissue, but not in the serum. 
Both vitamin E and chitosan are able to scavenge the free radicals produced by CCl4, thus 
maintaining the HD capacity at levels similar to that of the control group. But the reduced 
glutathione levels have a different dynamics. CCl4 administration decreases the tissue GSH 
level, while increasing the serum one. Therefore, after acute administration of the toxic only 
the liver GSH reserves are depleted. In the liver tissue, the effects of the vitamin E and 
chitosan supplementation on the GSH levels are similar to those on the HD capacity. 
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Fig. 3. The differences between hydrogen donor’s 
capacity levels in serum 
 
Fig. 4. The differences between hydrogen donor’s 
capacity levels in liver tissue 
  
Fig. 5. The differences between reduced glutathione 
serum levels 
Fig. 6. The differences between reduced glutathione 
liver tissue levels 
 
Our results are in agreement with those find in the literature. For instance, Yu (2007) 
shows that CCl4 administration reduces the glutathione level in the liver tissue. Also, 
MacDonald-Wicks and Garg (2003) showed that vitamin E administration improves the 
antioxidant defence markers, protecting them. Anraku et al. (2009) showed that water soluble 
chitosan can be also used as a dietary supplement and, after four weeks of supplementation it 
increases the total plasma antioxidant activity and reduces the albumin carbonyl levels, but 
these effects are dose-dependent. Since the antioxidant properties of the chitosan can be 
observed in normal subjects, there are serious perspectives to use it as a supplement during 
different disease, among which in liver diseases. Also, its antioxidant capacity is similar, even 
superior, to that of the vitamin C. In another recent study, Anraku et al. (2008) demonstrated 
that the low molecular weight chitosan is a potent inhibitor of the ROS production, thus 
offering an antioxidant protection of the human serum albumin. 
The histopathological examination did not identify changes in the liver tissue samples 
of the animals belonging to the control group (Fig. 7). For those receiving CCl4 (group II), we 
observed vacuolar dystrophy in the centrolobular area, acute inflammatory infiltrate (with a 
large number of neutrophils) and many eosinophils. Also, we can see lipid dystrophy and 
hepatocytes necrosis in the perivenular area (Fig. 8). The animals protected with vitamin E 
(group III) had perivenular fatty and vacuolar dystrophy and inflammatory infiltrate with a 
large number of neutrophils (Fig. 9), but the lesions are less severe than those of the animals 
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in group II. Finally, in the liver tissue of the animals protected with chitosan only mild lesions 
can be seen, with a few necrotic hepatocytes in the centrolobular area, a diffuse dilatation of 
the sinusoid capillaries, the inflammatory infiltrate being mild or even absent (Fig. 10). 
 
  
Fig. 7. Normal liver (group I) 
Masson’s trichrome stain (200x) 
Fig. 8. Liver tissue (group II: CCl4) 
Masson’s trichrome stain (200x) 
  
Fig. 9. Liver tissue (group III: CCl4+vit. E) 
Masson’s trichrome stain (100x) 
Fig. 10. Liver tissue (group IV: CCl4+CS) 
Masson’s trichrome stain (100x) 
 
The histopathological examination confirms the oxidative stress findings. CCl4 
induces severe liver lesions, while the chitosan protects against these oxidative injuries better 
than vitamin E.  
     CONCLUSIONS 
 
1. Acute carbon tetrachloride administration induces lipid peroxidation and leads to 
oxidative stress (MDA increased in comparison with the control group). 
2. Vitamin E supplementation reduces the oxidative stress both in blood serum and in 
liver tissue. 
3. Chitosan supplementation induces a significant decrease of the oxidative stress to 
values similar to those of the control group. 
4. The antioxidant effect of the chitosan on the lipid peroxidation is superior to that of 
the vitamin E. 
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